Alexandra Hotca-Cho

Dr. Alexandra Hotca-Cho serves as an Assistant Professor in the Department of Radiation Oncology within the School of Medicine at the University of California, San Francisco (UCSF). Her clinical expertise centers on gastrointestinal cancers, where she employs advanced radiation modalities such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and respiratory gating to maximize tumor control while reducing adverse effects. Dr. Hotca-Cho is committed to patient advocacy and delivering compassionate, high-quality care to UCSF's diverse patient community.

Her educational journey includes a Bachelor of Arts in Biology from Hunter College – CUNY (2014), followed by a Doctor of Medicine from Drexel University College of Medicine (2015-2019). She completed an Internal Medicine internship at Lenox Hill Hospital – Northwell Health (2019-2020) and a Radiation Oncology residency with a Chief Resident year at the Icahn School of Medicine at Mount Sinai (2020-2024).

Dr. Hotca-Cho's research program is dedicated to improving cancer survivorship through two primary avenues: (1) developing preventive strategies to mitigate treatment-related toxicities, and (2) discovering predictive biomarkers that identify patients at risk for radiation-induced complications. Her scholarly work spans gastrointestinal oncology, precision radiation delivery, health equity, and quality-of-life outcomes. Recent publications demonstrate her leadership in hepatocellular carcinoma, esophageal cancer, and the application of proton therapy for recurrent malignancies.

A review of her 15 most recent publications (2022-2024) highlights her focus on gastrointestinal malignancies and radiation toxicity management. Key themes include the safety of combined immunotherapy and radiation, predictive models for esophageal toxicity, and disparities in genomic testing and Medicaid coverage for cancer patients. Her work bridges clinical practice with translational research to enhance therapeutic precision.

Her accolades include the Resident Clinical Excellence Award from Mount Sinai Hospital (2024) and the prestigious Luther W. Brady, MD Award from Drexel University College of Medicine (2019), recognizing her outstanding clinical performance and academic promise.

While the source material does not specify current advisees or grant funding, Dr. Hotca-Cho's active research portfolio suggests ongoing mentorship of trainees and competitive research support. Similarly, no details about specific laboratories or research teams were provided, though her work likely involves multidisciplinary collaboration within UCSF's comprehensive cancer center.